glutathione mutations in sclc patients Tumor suppressor genes and KRAS G12C inhibitor resistance non-small cell lung cancer: iScience In vivo functional screens reveal

In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR Mutant Lung Cancer glutathione mutations in sclc patients Role of Cancer: From Mechanisms to Therapies Deep Clustering Based Metabolic Stratification of Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Cellular Compartmentalization, Glutathione Transport and Its Relevance in Some Pathologies Frontiers Molecular subtypes based on ferroptosis related genes and tumor microenvironment infiltration characterization in small cell lung cancer

SKU: 92818365598 · From reganhouse.co.nz